Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Eliane_IL2.Rapa bis


ABSTRACT: Administration of low-dose IL-2 prevents and cures type 1 diabetes (T1D) in NOD mice by boosting pancreatic regulatory T cells (Tregs) and is currently being evaluated in humans. Here, to improve treatment efficacy we tested higher IL-2 doses that, despite further boosting Tregs, rapidly precipitated T1D in pre-diabetic mice due to generalized immune activation. Although the combination of rapamycin (RAPA) plus IL-2 prevents NOD T1D development, a recent clinical trial translating this strategy into patients was halted due to C-peptide decline. Here, we show that RAPA/IL-2 combination was also ineffective to cure new onset T1D in mice and, surprisingly, RAPA broke IL-2-induced tolerance in a reversible way. RAPA partially counteracted IL-2 effects on Tregs and the combined treatment unexpectedly, impaired glucose homeostasis at multiple levels, possibly explaining the clinical outcome. Our data help understand IL-2 alone or RAPA/IL-2 combination limitations and could lead to the design of improved T1D therapies.

ORGANISM(S): Mus musculus

SUBMITTER: Nicolas Cagnard 

PROVIDER: E-MEXP-3789 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Similar Datasets

2009-12-04 | E-TABM-653 | biostudies-arrayexpress
2013-01-24 | E-MEXP-3522 | biostudies-arrayexpress
2011-03-21 | E-MEXP-2689 | biostudies-arrayexpress
2013-01-16 | E-MEXP-3518 | biostudies-arrayexpress
2012-08-30 | E-MEXP-3512 | biostudies-arrayexpress
2009-09-15 | E-TABM-548 | biostudies-arrayexpress
2005-11-10 | E-MEXP-481 | biostudies-arrayexpress
2007-01-09 | E-MEXP-527 | biostudies-arrayexpress
2007-12-10 | E-MEXP-482 | biostudies-arrayexpress
2010-10-12 | E-GEOD-14328 | biostudies-arrayexpress